Agendia Opens CLIA-Registered U.S. Genomics ... (enter Los Angeles.Dr. Henning is a Fello...)

Agendia Opens CLIA-Registered U.S. Genomics Laboratory

Date:5/26/2009

enter, Los Angeles. Dr. Henning is a Fellow of the American Society of Clinical Pathologists and the College of American Pathologists.

Ongoing research and development commitments continue to augment Agendia's ability to accurately predict breast cancer recurrence and sub-typing, and help physicians tailor individual treatment plans to their patients. Agendia's goal is to provide women with answers to crucial treatment questions, such as how their breast cancer will respond to targeted therapies or various chemotherapy regimens.

For more information, please visit http://www.agendia.com

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of oncology. Agendia was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
2. Agendia to Present at BioCenturys Future Leaders in the Biotech Industry Conference
3. Agendia Presents Data Supporting MammaPrints Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference
4. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
5. Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
6. Agendia Appoints VP of Business Development
7. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
8. Agendia Appoints New Chief Financial Officer
9. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
10. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
11. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...

(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...

(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...

(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress

... China, Sept. 5 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-,Pharmaceutical Technology, ... developer and producer of plant extracts and pharmaceutical ... production in,Xi,an, China, is pleased to announce a ... with Xi,an Qinba Xintong Medical Ltd. ("Qinba").,Under the ...

... MATEO, Calif., Sept. 4 BioForm Medical,Inc. (Nasdaq: BFRM ... full fiscal year ended June 30, 2008. Net sales were ... to $15.4 million,for the quarter ended June 30, 2007, an ... million for the quarter ended June 30, 2008 as,compared to ...

... COLUMBUS, Ohio, Sept. 4 The Ohio State ... country to discuss,translating scientific breakthroughs in the laboratory ... Health Care Conference on,Oct. 16-17., Health care ... experts, academic leaders, and consumer and patient,advocacy groups ...

Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd.BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 OSU to Host National Personalized Health Care Conference

(Date:12/14/2009)... founded a new journal Cardiovascular Engineering and Technology ... a forum for research on all aspects of cardiovascular ... the new quarterly journal will appear in March 2010 ... Annals of Biomedical Engineering and Cellular and ... will present a wide spectrum of research, from ...

(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...

(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...

Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2 Tool use in an invertebrate: The coconut-carrying octopus 2 American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 1 American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 2 Human Genome Sciences Announces Closing of Public Offering 13334 1 Human Genome Sciences Announces Closing of Public Offering 13334 2 Human Genome Sciences Announces Closing of Public Offering 13334 3 National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 1 National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 2

[0] Biomedical Engineering Society's new journal to be published by Springer [0] When it comes to fish families, the bigger and bossier the better [0] Tool use in an invertebrate: The coconut-carrying octopus

... Bulletin Board: BKYI) today announced plans to release first quarter,2008 ... opens.,In conjunction with the release, BIO-key has scheduled a conference ... May 15, 2008 at,9:00 a.m. Eastern Time., What: ... Call ...

... What if hydrology is more important for predicting biodiversity ... the journal Nature challenges current thinking about biodiversity and ... or human activity may affect biodiversity patterns. , ... that the biodiversity of fish species in a river ...

... of the genome sequence of the duck-billed platypus was ... clues about how genomes were organized during the early ... by the National Human Genome Research Institute (NHGRI), part ... of TV nature shows will remember that the duck-billed ...

Other Biology News:BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2 Biodiversity -- it's in the water 2 Duck-billed platypus genome sequence published 2 Duck-billed platypus genome sequence published 3 Duck-billed platypus genome sequence published 4

BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule Biodiversity -- it's in the water Duck-billed platypus genome sequence published

Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...

Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...

... These primers are designed for sequencing ... the SP6, T7, or T3 RNA polymerase ... They are supplied at a concentration of ... functionally tested in DNA sequencing reactions using ...

... powerful application for DNA and protein ... Expression makes complex computational analyses of ... the very latest computing technology to ... sequences are analysed. Features include: Sequence ...

Biology Products:

BD BioCoat Poly-D-Lysine 35 mm Culture Dishes from BD Biosciences - Discovery Labware Rabbit Anti-Synapsin II Polyclonal Antibody, Unconjugated from Abcam Lambda GT11 Forward DNA Sequencing Primer from EPICENTRE Biotechnologies Expression from Genamics

Agendia Opens CLIA-Registered U.S. Genomics ...(enter Los Angeles.Dr. Henning is a Fello...)